Literature DB >> 1984336

Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: effects of selenium yeast, selenite, and selenate.

G Alfthan1, A Aro, H Arvilommi, J K Huttunen.   

Abstract

The mean dietary selenium intake in Finland increased from 40 to 100 micrograms/d in 1987 because of the addition in 1985 of selenium to fertilizers. A selenium-supplementation study was performed in 1987 on the same men as were followed in a 1981 study that had a similar design (200 micrograms Se/d). Selenite and selenate, but not selenium yeast increased platelet glutathione peroxidase (GSHPx) activity by 30% compared with placebo, much less than the 70% found in the previous study. Selenium yeast and selenite increased plasma selenium after 11 wk from 1.39 mumol/L to peak values of 2.15 and 1.58 mumol/L, respectively. Only yeast selenium was incorporated into red cells. From a regression plot based on present and literature data, it was estimated that the plasma selenium concentration needed to achieve maximal platelet GSHPx activity was 1.25-1.45 mumol/L. At the present selenium intake in Finland, 100 micrograms/d, GSHPx activity is saturated in plasma and red cells and almost saturated in platelets.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1984336     DOI: 10.1093/ajcn/53.1.120

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  26 in total

Review 1.  Selenium metabolism and bioavailability.

Authors:  L A Daniels
Journal:  Biol Trace Elem Res       Date:  1996-09       Impact factor: 3.738

2.  The effect of nationwide selenium enrichment of fertilizers on selenium status of healthy Finnish medical students living in south western Finland.

Authors:  A L Mäkelä; V Näntö; P Mäkelä; W Wang
Journal:  Biol Trace Elem Res       Date:  1993-02       Impact factor: 3.738

3.  Biological monitoring of exposure and effects in workers employed in a selenium-processing plant.

Authors:  Th Göen; B Schaller; Th Jäger; Ch Bräu-Dümler; K H Schaller; H Drexler
Journal:  Int Arch Occup Environ Health       Date:  2014-10-04       Impact factor: 3.015

4.  Age-related cataract in men in the selenium and vitamin e cancer prevention trial eye endpoints study: a randomized clinical trial.

Authors:  William G Christen; Robert J Glynn; J Michael Gaziano; Amy K Darke; John J Crowley; Phyllis J Goodman; Scott M Lippman; Thomas E Lad; James D Bearden; Gary E Goodman; Lori M Minasian; Ian M Thompson; Charles D Blanke; Eric A Klein
Journal:  JAMA Ophthalmol       Date:  2015-01       Impact factor: 7.389

Review 5.  Glutathione peroxidase 4: a new player in neurodegeneration?

Authors:  B R Cardoso; D J Hare; A I Bush; B R Roberts
Journal:  Mol Psychiatry       Date:  2016-10-25       Impact factor: 15.992

6.  Enteral yeast-selenium supplementation in preterm infants.

Authors:  G Bogye; G Alfthan; T Machay; L Zubovics
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

Review 7.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 8.  Selenium and cancer: biomarkers of selenium status and molecular action of selenium supplements.

Authors:  Jolanta Gromadzińska; Edyta Reszka; Katharina Bruzelius; Wojciech Wasowicz; Björn Akesson
Journal:  Eur J Nutr       Date:  2008-05       Impact factor: 5.614

9.  Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue.

Authors:  Yumie Takata; J Steven Morris; Irena B King; Alan R Kristal; Daniel W Lin; Ulrike Peters
Journal:  Prostate       Date:  2009-11-01       Impact factor: 4.104

Review 10.  Nutrition and lung cancer.

Authors:  R G Ziegler; S T Mayne; C A Swanson
Journal:  Cancer Causes Control       Date:  1996-01       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.